|
⚲
|
| Keyboard |
| Vickers Venture Fund VI Pte Ltd
✚
|
|
|---|---|
| CIK # | 0001839162 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001839162] | |
| 4 | [0001839162] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vickers Venture Fund VI Pte Ltd | |
| Aardvark Therapeutics Inc | |
| Ho Chris | |
| Vickers Venture Fund VI Plan Pte Ltd | |
| Chi Jeffrey | |
| Scilex Holding Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aardvark Therapeutics Inc AARD
Common Stock
|
2025-02-14 | Conversion | 1,637,411 | ||
|
Aardvark Therapeutics Inc AARD
Common Stock
|
2025-02-14 | Conversion | 413,491 | ||
|
Aardvark Therapeutics Inc AARD
Series A Convertible Preferred Stock · derivative
|
2025-02-14 | Conversion | 13,875,429 | $0.00 | |
|
Aardvark Therapeutics Inc AARD
Series B Convertible Preferred Stock · derivative
|
2025-02-14 | Conversion | 3,503,919 | $0.00 | |
|
Scilex Holding Co VCKAU
Warrants · derivative
|
2022-11-10 | Other | 578,160 | ||
|
Scilex Holding Co VCKAU
Warrants · derivative
|
2022-11-10 | Other | 5,261,840 |